Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

The University of Hong Kong · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
fatty-liver
non-alcoholic fatty liver disease, nafld, nash, fatty liver, empagliflozin, sglt2 inhibitors, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 900128
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.